IXICO (LON:IXI) Releases Earnings Results

IXICO (LON:IXI) released its quarterly earnings results on Tuesday. The company reported GBX (1.21) EPS for the quarter, Digital Look Earnings reports. IXICO had a negative return on equity of 13.74% and a negative net margin of 25.27%.The business had revenue of GBX 395 million for the quarter.

IXICO Price Performance

LON:IXI opened at GBX 8 on Tuesday. IXICO has a 52 week low of GBX 6.26 and a 52 week high of GBX 15. The firm has a market cap of £17.44 million, a price-to-earnings ratio of -4.32, a P/E/G ratio of -0.38 and a beta of 0.07. The firm’s 50-day simple moving average is GBX 7.34 and its 200 day simple moving average is GBX 9.48. The company has a debt-to-equity ratio of 1.53, a quick ratio of 4.90 and a current ratio of 3.03.

IXICO Company Profile

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.